MIT Technology Review – The patent judges’ decision—expected in early 2017—is not likely to put any CRISPR companies out of business or even slow the lightning pace of research and development in commercial laboratories, experts say.
The New England Journal of Medicine – Here, we focus on aspects of the Cures Act that are directly relevant to the NIH’s mission — measures that will provide the agency with critical tools and resources to advance biomedical research across the spectrum.
USA TODAY – With $500 million in hand to fight the opioid epidemic, White House officials are moving quickly to get that money flowing to the hardest-hit states—and pushing local officials to spend the new dollars on treatment above other addiction-related initiatives.
GenomeWeb – Genes that are essential for survival and development harbor an increased burden of variants in people with autism spectrum disorder, according to researchers from the University of Pennsylvania.
Stanford University – With every toilet flush, valuable information encrypted in DNA is lost. Wastewater may hold a wealth of insight for public health officials, and an interdisciplinary team of researchers is keen on tapping into it.